Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 776,985Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9SUCAMPO PHARMA LLC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LUBIPROSTONE

US Patent Number : 7795312

Drug Substance Claim :

Drug Product Claim :

Application Number : 21908

Patent Use Code : U-1085

Delist Requested :

Patent Use Description : METHOD FOR TREATING IR...

Patent Expiration Date : 2024-09-17

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LUBIPROSTONE

US Patent Number : 8748481

Drug Substance Claim :

Drug Product Claim :

Application Number : 21908

Patent Use Code : U-1519

Delist Requested :

Patent Use Description : METHOD FOR THE LONG TE...

Patent Expiration Date : 2025-09-01

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LUBIPROSTONE

US Patent Number : 8748481

Drug Substance Claim :

Drug Product Claim :

Application Number : 21908

Patent Use Code : U-1520

Delist Requested :

Patent Use Description : METHOD FOR THE LONG TE...

Patent Expiration Date : 2025-09-01

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LUBIPROSTONE

US Patent Number : 8779187

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21908

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-01-23

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LUBIPROSTONE

US Patent Number : 8779187

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21908

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-01-23

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LUBIPROSTONE

US Patent Number : 8026393

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21908

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-10-25

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LUBIPROSTONE

US Patent Number : 8026393

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21908

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-10-25

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LUBIPROSTONE

US Patent Number : 8338639

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21908

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-01-23

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LUBIPROSTONE

US Patent Number : 8338639

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21908

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-01-23

blank